Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R01 Clinical Trial Optional)
Closed Posted
- Opportunity number
- PAR-25-065
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Applications due
- Award size
- Not on record
Opportunity facts
- Assistance listings
-
- 93.242 Mental Health Research Grants
- 93.866 Aging Research
- Funding instrument
- Grant
- Category
-
- Health
- Eligible applicants
-
- Special District Governments
- Small Businesses
- Non-501(c)(3) Nonprofits
- Other
- State Governments
- Higher Education Inst. (Public)
- City/Township Governments
- Public or Indian Housing Auth.
- County Governments
- For Profit Organizations
- Tribal Organizations (Not Federally Recognized)
- 501(c)(3) Nonprofits
- Tribal Governments (Federally Recognized)
- Independent School Districts
- Higher Education Inst. (Private)
- Full announcement
Opportunity details come from Grants.gov. Updated .
About this opportunity
The Department of Health and Human Services' National Institutes of Health, specifically the National Institute of Mental Health (NIMH) and the National Institute on Aging (NIA), is seeking grant applications for studies that will enhance knowledge of mechanisms associated with neuropsychiatric symptoms in Alzheimer's disease and related dementias. The goal is to advance understanding of the biobehavioral and neurobiological pathways leading to these symptoms, with the intent of informing the development of novel therapeutic targets. Eligible applicants include a range of organizations such as nonprofits, state/local governments, small businesses, and tribal entities. The opportunity is funded under the NIMH's Mental Health Research Grants program (CFDA 93.242) and the NIA's Aging Research program (CFDA 93.866).
No specific award amounts or budget ranges are provided in the announcement. The funding opportunity does not specify a target number of awards or a timeline for the funded projects. The research activities are expected to be conducted at the facilities of the recipient organizations across the United States.
Synopsis
The goal of this Funding Opportunity Announcement (FOA) is to encourage applications for studies that will enhance knowledge of mechanisms associated with neuropsychiatric symptoms (NPS) in persons with Alzheimer's disease (AD) or Alzheimer's disease-related dementias (ADRD). The findings are expected to advance mechanistic understanding of both biobehavioral and neurobiological pathways leading to NPS. Findings may also provide insight into novel therapeutic targets that can be advanced into interventions to treat and prevent the development of NPS in AD and/or ADRD
Files
| File | Type | Posted |
|---|---|---|
| PAR-25-065-Full-Announcement.html | HTML file |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity